MD529Y - Metodă de pronostic al evoluţiei insuficienţei cardiace congenitale la copii, complicată cu hipertensiune pulmonară - Google Patents

Metodă de pronostic al evoluţiei insuficienţei cardiace congenitale la copii, complicată cu hipertensiune pulmonară Download PDF

Info

Publication number
MD529Y
MD529Y MDS20110167A MDS20110167A MD529Y MD 529 Y MD529 Y MD 529Y MD S20110167 A MDS20110167 A MD S20110167A MD S20110167 A MDS20110167 A MD S20110167A MD 529 Y MD529 Y MD 529Y
Authority
MD
Moldova
Prior art keywords
evolution
complicated
heart failure
pulmonary hypertension
predicting
Prior art date
Application number
MDS20110167A
Other languages
English (en)
Russian (ru)
Inventor
Ina Palii
Eleonora Vataman
Constantin Jucovschi
Original Assignee
Ina Palii
Eleonora Vataman
Constantin Jucovschi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ina Palii, Eleonora Vataman, Constantin Jucovschi filed Critical Ina Palii
Priority to MDS20110167A priority Critical patent/MD529Y/ro
Publication of MD529Y publication Critical patent/MD529Y/ro

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Invenţia se referă la medicină, în special la cardiologia pediatrică.Metoda de pronostic al evoluţiei insuficienţei cardiace congenitale la copii, complicată cu hipertensiune pulmonară include examenul clinic şi paraclinic cu stabilirea următorilor parametri: agravarea bruscă a dispneei (ABD), tipul anatomo-fiziopatologic al şuntului pulmonar (TAFŞP), corecţia chirurgicală (SCC), trisomia cromozomului 21 (DOWN), starea extremităţilor (EMR), tulburările de creştere a copilului (TCC), detresia respiratorie (DR), sincope de efort (SIN) şi jugularea turgescentă sau bombarea fontanelelor (BF), apoi se calculează funcţia discriminantă (F) conform formulei:F = 1,4191 × ABD + 0,2033 × TAFŞP - 0,6872 × SCC + 0,1794 × DOWN + 0,7636 × TCC + 2,1352 × SIN + 1,1020 × BF + 0,9071 × DR + 1,9588 × EMR - 4,0946.În cazul în care F < 0 se pronostichează o evoluţie favorabilă, iar când F > 0 - o evoluţie nefavorabilă a insuficienţei cardiace complicate cu hipertensiune pulmonară.
MDS20110167A 2011-11-01 2011-11-01 Metodă de pronostic al evoluţiei insuficienţei cardiace congenitale la copii, complicată cu hipertensiune pulmonară MD529Y (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20110167A MD529Y (ro) 2011-11-01 2011-11-01 Metodă de pronostic al evoluţiei insuficienţei cardiace congenitale la copii, complicată cu hipertensiune pulmonară

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20110167A MD529Y (ro) 2011-11-01 2011-11-01 Metodă de pronostic al evoluţiei insuficienţei cardiace congenitale la copii, complicată cu hipertensiune pulmonară

Publications (1)

Publication Number Publication Date
MD529Y true MD529Y (ro) 2012-07-31

Family

ID=46582444

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20110167A MD529Y (ro) 2011-11-01 2011-11-01 Metodă de pronostic al evoluţiei insuficienţei cardiace congenitale la copii, complicată cu hipertensiune pulmonară

Country Status (1)

Country Link
MD (1) MD529Y (ro)
  • 2011

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Dickstein K, Cohen-Solal A, Filipatos G, et al . Diagnosis and Treatment of Acute and Chronic Heart failure of European Society of Cardiology. Developed in colaboration with the heart failure association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine.ESC Guidelinis for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J, 2008, vol. 29, p. 2388-2442. *
Guimaras G.V., Moraes d'Avila V., Camargo P.R. et al. Prognostic value of cardiopulmonary exercise testing in children with heart failure secondary to idiopathic dilated cardiomyopathy in a non b-bloker therapy seting. European Journal of Heart Failure, 2008, vol. 10, p. 560-565 *
Smith ORF, Michielsen HJ, Pelle AJ, Symptoms of fatigue in chronic heart failure patient: Clinical and psychological predictos. European Journal of Heart Failure, 2007, vol. 9, p. 922-927 *

Similar Documents

Publication Publication Date Title
AU2018253580A1 (en) Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
AU2011286276A8 (en) Substituted Biphenylene Compounds and methods of use thereof for the treatment of viral diseases
EP4219400A3 (en) Method for producing lithium fluorosulfonate, lithium fluorosulfonate, use of lithium fluorosulfonate in a nonaqueous electrolytic solution, and nonaqueous electrolytic solution
UA107115C2 (uk) Тіоацетатні похідіні піридину, композиція на їх основі та їх застосування
EA201300669A1 (ru) Замещенные 1-бензилциклоалкилкарбоновые кислоты и их применение
MX2012012952A (es) Compuestos de 2, 5, 6, 7,-tetrahidro-[1, 4] oxazepin-3-ilamina o 2, 3, 6, 7-tetrahidro-[1, 4] oxazepin-5-ilamina.
WO2012117316A3 (en) Patient deterioration detection
NZ595307A (en) Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
WO2013071280A3 (en) Determination for effective defibrillation
WO2009145456A3 (ko) 헤테로사이클 유도체
MX2018003649A (es) Metodos e intermedios para la preparacion de derivados de acido biliar.
WO2014099633A3 (en) Inhibitors of the renal outer medullary potassium channel
EA201370106A1 (ru) Способ получения низших хлоридов титана
JO3510B1 (ar) استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
MX356951B (es) Estabilizacion de fsh.
WO2012065110A3 (en) S-protected cysteine analogs and related compounds
MX352904B (es) Compuestos de piridina 3,4-di-sustituido, procedimientos de uso y composiciones que comprenden el mismo.
MX2012000267A (es) Derivados de pirazoles, y su preparacion y su uso en terapeutica.
UA101091C2 (ru) Способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой
NZ751256A (en) Method for producing the crystalline form of modification a of calcobutrol
MX2012002818A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
IL225557A (en) Preparation Method (3s, 3s) 4,4&#39;-Disulfandylbis (3-Aminobutane 1 - Sulfonic Acid)
PT2247573E (pt) Sais carbónicos e de ácido sulfúrico de ésteres de 3-(2,2,2- trimetil-hidrazínio)propionato e sua utilização para a preparação de di-hidrato de 3-(2,2,2-trimetilhidrazínio) propionato
MX337997B (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
MD530Y (ro) Metodă de pronostic al evoluţiei insuficienţei cardiace congenitale la copii, complicată cu hipertensiune pulmonară

Legal Events

Date Code Title Description
KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)